Global
Site
Site
James Smith
Business Development Associate
James is a DPhil (PhD) researcher working on predicting the regulatory approval of early stage medicines using machine learning, and on improving IP landscaping practices. He has experience working as a consultant on a range of early stage biotech and medtech asset-focussed projects. Prior to his DPhil, James was a research scholar at the Harvard Stem Cell Institute, and completed his undergraduate degree in Biological Sciences at Oxford.
